InsidersTradesSigma
Aarti Drugs Limited: management transactions · India · SEBI (PIT + SAST)
SEBI:aarti-drugs-limitedIN·SEBI (PIT + SAST)Mcap 31.0Bn€
Browse the full management transaction log of Aarti Drugs Limited, a publicly traded company based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Market capitalisation: €31bn. The latest transaction was disclosed on 1 April 2022 — Purchase. Among the most active insiders: Safechem Enterprises Private Limited. All data is openly available.
67
Insider Decl.
0
Thresholds
€2m
16 ops.
Buy Volume
€8m
51 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
365.90 €
Income statement
Revenue23.69 Bn€
Gross profit8.45 Bn€36% margin
Net income1.68 Bn€7.1% margin
Balance sheet & cash
Market cap31.01 Bn€
Total debt6.15 Bn€
Free Cash Flow674.2 M€
Last declaration on 1 April 2022
Declarations67 total
Executives●Purchase0SEBI
€277,97653,500 shares@ €5.1958
Equity Shares
SEBI:7ebe6f289a05c28eb6e8501faf6fa394e23439f6·
Ideal exit: 26 Dec 2022 (T+270)
Executives●Purchase0SEBI
€130,95525,000 shares@ €5.2382
Equity Shares
SEBI:747147572648e5e25866cf3fc68dd6efdb9fa581·
Ideal exit: 26 Dec 2022 (T+270)
Executives●Sale0SEBI
€856,509164,500 shares@ €5.2067
Equity Shares
SEBI:3a9fe497324dac3c2285044272b150405bdf912a·
Executives●Purchase0SEBI
€73,33514,000 shares@ €5.2382
Equity Shares
SEBI:705cb443842637d2a2db1fe008dae568c5d04138·
Ideal exit: 26 Dec 2022 (T+270)
Executives●Purchase0SEBI
€57,62111,000 shares@ €5.2382
Equity Shares
SEBI:4c7b82e7d5ad6bb2bba5c445d591797c0c9b31d6·
Ideal exit: 26 Dec 2022 (T+270)
Executives●Purchase0SEBI
€261,88450,000 shares@ €5.2377
Equity Shares
SEBI:772990de212fbe437710799e3934274cb217caf4·
Ideal exit: 26 Dec 2022 (T+270)
Executives●Purchase0SEBI
€631,359120,000 shares@ €5.2613
Equity Shares
SEBI:4cb306523b3cff167265c8eaccd8fb3d6fd2bf08·
Ideal exit: 23 Dec 2022 (T+270)
Executives●Purchase0SEBI
€366,96370,000 shares@ €5.2423
Equity Shares
SEBI:4dd9d6ec3cd7435e359970ce740b30cd8c75106c·
Ideal exit: 23 Dec 2022 (T+270)
Executives●Sale0SEBI
€947,569180,615 shares@ €5.2463
Equity Shares
SEBI:9e317954615d4f72aad39c2c6b33b859a0370625·
Executives●Purchase0SEBI
€3,313609 shares@ €5.4397
Equity Shares
SEBI:291c302e44702c60108378a3b14559eb6e4281b3·
Ideal exit: 27 Nov 2022 (T+270)
Executives●Purchase0SEBI
€3,046500 shares@ €6.0913
Equity Shares
SEBI:628de7709512da35f476ccd9d68b904cdfbb417b·
Ideal exit: 16 Sept 2022 (T+270)
Executives●Purchase0SEBI
€12420 shares@ €6.2128
Equity Shares
SEBI:3206cff2e73608a9d0375a3fed090c3190f2a56c·
Ideal exit: 21 Aug 2022 (T+270)
Executives●Purchase0SEBI
€2,698500 shares@ €5.3956
Equity Shares
SEBI:eed19423223a3c4a224e31e9f0dab6e1b1a38dc8·
Ideal exit: 25 Nov 2022 (T+270)
Executives●Purchase0SEBI
€3,040500 shares@ €6.0799
Equity Shares
SEBI:a1d92dbd4a5f7f0bd032964a1312b71fbddf2ef0·
Ideal exit: 28 Aug 2022 (T+270)
Executives●Purchase0SEBI
€50,5128,600 shares@ €5.8735
Equity Shares
SEBI:b00f8633b13ba29b8481f45487a317d3cfbf87e8·
Ideal exit: 12 Nov 2022 (T+270)
Executives●Sale0SEBI
€61,80810,000 shares@ €6.1808
Equity Shares
SEBI:3e15f0aadcb9df236aa025e38d215cf3f70ecc06·
Executives●Sale0SEBI
€441,62071,258 shares@ €6.1975
Equity Shares
SEBI:ff9bd60328c1d7a36c7c8315373282d9ca146315·
Executives●Sale0SEBI
€81,28013,120 shares@ €6.1951
Equity Shares
SEBI:d15ece23fe7275bb06d4145c4ad33b62f4bde008·
Executives●Sale0SEBI
€53,1228,705 shares@ €6.1025
Equity Shares
SEBI:be1f323b539b4719e2257bdf50cb32b5ca21cc5e·
Executives●Sale0SEBI
€276,74545,000 shares@ €6.1499
Equity Shares
SEBI:f86e303f1bce743f0148e37e7c58c9aecb569798·
Executives●Sale0SEBI
€11,7201,917 shares@ €6.1139
Equity Shares
SEBI:70713a810f0014cfb0ba8d519edd770551804385·
Executives●Purchase0SEBI
€1,211200 shares@ €6.0551
Equity Shares
SEBI:3c10af7cc70cfd376b05420835f7e57129416b71·
Ideal exit: 17 Sept 2022 (T+270)
Executives●Purchase0SEBI
€64,64110,741 shares@ €6.0181
Equity Shares
SEBI:280e403ce2e39363ac5a4224f3f94a251f92548c·
Ideal exit: 28 Aug 2022 (T+270)
Executives●Purchase0SEBI
€117,58019,200 shares@ €6.1239
Equity Shares
SEBI:d97b94d555595295656c643f997bec9d945c325f·
Ideal exit: 27 Aug 2022 (T+270)
Executives●Sale0SEBI
€138,35419,647 shares@ €7.042
Equity Shares
SEBI:25e8608ef38e5ffab2db757188b904240293fbc5·
25 of 67 declarations
About Aarti Drugs Limited
Aarti Drugs Limited is an Indian company engaged in the manufacturing of pharmaceutical products. It is listed on the Bombay Stock Exchange.